| Entry |
|
|---|
| Name |
Tolazoline hydrochloride (JAN/USP);
Priscoline (TN) |
|---|
| Formula |
C10H12N2. HCl
|
|---|
| Mass |
196.0767 |
|---|
| Structure |
     |
|---|
| Pathway |
hsa04020 Calcium signaling pathway
hsa04080 Neuroactive ligand-receptor interaction
hsa04270 Vascular smooth muscle contraction
|
|
|---|
| Target |
alpha1-adrenergic receptor antagonist [HSA:148 147 146];
alpha2-adrenergic receptor antagonist [HSA:150 151 152] |
|---|
| Interaction |
 |
|---|
| Activity |
Vasodilator [peripheral] |
|---|
| Remark |
Therapeutic category: 1234
ATC code: C04AB02 M02AX02
 |
|---|
| Structure map |
map07215 alpha-Adrenergic receptor agonists/antagonists |
|---|
| Products |
|
|---|
| Other DBs |
CAS: 59-97-2
PubChem: 7848060
DrugBank: DB00797
LigandBox: D00997
NIKKAJI: J231.280H |
|---|
| KCF data |
 |
|---|
